Natural killer alloeffector responses in haploidentical hemopoietic stem cell transplantation to treat high-risk leukemias

Tissue Antigens

Volumn 75, Issue 2, 2010, Pages 103-109

  Moretta, L ^a,b   Locatelli, F ^c   Pende, D ^d   Mingari, M C ^a,d   Moretta, A ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Activating receptors; Acute lymphoblastic leukemias; Acute myeloid leukemias; Hemopoietic stem cell transplantation; Killer immunoglobulin like receptors; Killer immunoglobulin like repertoire; Natural killer cells

Indexed keywords

CD34 ANTIGEN; HLA ANTIGEN CLASS 1;

ALLOIMMUNITY; CYTOKINE RELEASE; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; INFLAMMATION; INNATE IMMUNITY; LEUKEMIA; NATURAL KILLER CELL; PRIORITY JOURNAL; REVIEW;

ACUTE DISEASE; ADULT; CHILD; GRAFT REJECTION; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; LEUKEMIA; LEUKOCYTES; RISK; T-LYMPHOCYTES;

EID: 73949101184     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2009.01404.x     Document Type: Review

References (77)

1. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989 : 47 : 187 376.
2. Moretta L, Ciccone E, Mingari MC, Biassoni R, Moretta A. Human NK cells: origin, clonality, specificity and receptors. Adv Immunol 1994 : 55 : 341 380. (Pubitemid 24057057)
3. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002 : 20 : 197 216.
4. Moretta L, Moretta A. Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J 2004 : 23 : 255 259. (Pubitemid 38294490)
5. Parham P. The unsung heroes. Nature 2003 : 423 : 20.
6. Moretta A, Bottino C, Mingari MC, Biassoni R, Moretta L. What is a Natural Killer cell? Nat Immunol 2002 : 3 : 6 8.
7. Moretta A, Bottino C, Vitale M et al. Receptors for HLA-class I molecules in human Natural Killer cells. Annu Rev Immunol 1996 : 14 : 619 648.
8. Lanier LL. NK cell receptors. Annu Rev Immunol 1998 : 16 : 359 393.
9. Long EO. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol 1999 : 17 : 875 904.
10. Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 2002 : 20 : 217 251.
11. Lopez-Botet M, Llano M, Navarro F, Bellon T. NK cell recognition of non-classical HLA class I molecules. Semin Immunol 2000 : 12 : 109 219.
12. Moretta A, Bottino C, Vitale M et al. Activating receptors and co-receptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001 : 19 : 197 223.
13. Moretta A, Biassoni R, Bottino C, Mingari MC, Moretta L. Natural cytotoxicity receptors that trigger human NK-mediated cytolysis. Immunol Today 2000 : 21 : 228 234.
14. Sivori S, Vitale M, Morelli L et al. p46, a novel Natural Killer cell-specific surface molecule which mediates cell activation. J Exp Med 1997 : 186 : 1129 1136.
15. Pessino A, Sivori S, Bottino C et al. Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J Exp Med 1998 : 188 : 953 960.
16. Pende D, Parolini S, Pessino A et al. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J Exp Med 1999 : 190 : 1505 1516.
17. Vitale M, Bottino C, Sivori S et al. NKp44, a novel triggering surface molecule specifically expressed by activated Natural Killer cells is involved in non-MHC restricted tumor cell lysis. J Exp Med 1998 : 187 : 2065 2072.
18. Cantoni C, Bottino C, Vitale M et al. NKp44, a triggering receptor involved in tumor cell lysis by activated human Natural Killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med 1999 : 189 : 787 796.
19. Walzer T, Bléry M, Chaix J et al. Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. Proc Natl Acad Sci USA 2007 : 104 : 3384 3389.
20. Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 2003 : 3 : 781 790.
21. Houchins JP, Yabe T, McSherry C, Bach FH. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J Exp Med 1991 : 173 : 1017 1020.
22. Cerwenka A, Lanier LL. Ligands for natural killer cell receptors: redundancy or specificity. Immunol Rev 2001 : 181 : 158 169.
23. Moretta A, Bottino C, Tripodi G et al. Novel surface molecules involved in human NK cell activation and triggering of the lytic machinery. Int J Cancer 1992 : (Suppl 7) : 6 10.
24. Valiante NM, Trinchieri G. Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes. J Exp Med 1993 : 178 : 1397 1406.
25. Sivori S, Parolini S, Falco M et al. 2B4 functions as a co-receptor in human natural killer cell activation. Eur J Immunol 2000 : 30 : 787 793.
26. Brown MH, Boles K, van der Merwe PA, Kumar V, Mathew PA, Barclay AN. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J Exp Med 1998 : 188 : 2083 2090.
27. Bottino C, Falco M, Parolini S et al. NTB-A, a Novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative diseases. J Exp Med 2001 : 194 : 235 246.
28. Falco M, Marcenaro E, Romeo E et al. Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells. Eur J Immunol 2004 : 34 : 1663 1672.
29. Vitale M, Falco M, Castriconi R et al. Identification of NKp80, a novel triggering molecule expressed by human natural killer cells. Eur J Immunol 2001 : 31 : 233 242.
30. Welte S, Kuttruff S, Waldhauer I, Steinle A. Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction. Nat Immunol 2006 : 12 : 1334 1342.
31. Shibuya A, Campbell D, Hannum C et al. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity 1996 : 4 : 573 581.
32. Bottino C, Castriconi R, Pende D et al. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med 2003 : 198 : 557 567.
33. Reymond N, Imbert A-M, Devilard E et al. DNAM-1 and PVR regulate of monocyte migration through endothelial junctions. J Exp Med 2004 : 199 : 1331 1341.
34. Raulet DH, Vance RE. Self-tolerance of natural killer cells. Nat Rev Immunol 2006 : 6 : 520 531.
35. Bennet M. Biology and genetics of hybrid resistance. Adv Immunol 1987 : 41 : 333 445.
36. Moretta A, Tambussi G, Bottino C et al. A novel surface antigen expressed by a subset of human CD3-CD 16+ Natural Killer cells. Role in cell activation and regulation of cytolytic function. J Exp Med 1990 : 171 : 695 714.
37. Moretta A, Bottino C, Pende D et al. Identification of four subset of human CD3-CD 16+ NK cells by the expression of clonally distributed functional surface molecules. Correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J Exp Med 1990 : 172 : 1589 1598.
38. Moretta A, Vitale M, Bottino C et al. p58 molecules as putative receptors for MHC class I molecules in human Natural Killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J Exp Med 1993 : 178 : 597 604.
39. Wagtmann N, Biassoni R, Cantoni C et al. Molecular clones of the p58 Natural Killer cell receptor reveal Ig-related molecules with diversity in both the extra- and intracellular domains. Immunity 1995 : 2 : 439 449.
40. Colonna M, Samaridis J. Cloning of immunoglobulin superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 1995 : 268 : 405 408.
41. Litwin V, Gumperz J, Parham P, Phillips JH, Lanier LL. NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules. J Exp Med 1994 : 180 : 537 544.
42. Vitale M, Sivori S, Pende D et al. Physical and functional independency of p70 and p58 NK cell receptors for HLA-class I. Their role in the definition of different groups of alloreactive NK cell clones. Proc Natl Acad Sci USA 1996 : 93 : 1453 1457.
43. Pende D, Biassoni R, Cantoni C et al. The Natural Killer cell receptor specific for HLA.A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140 kD disulphide-linked dimer. J Exp Med 1996 : 184 : 505 518.
44. Döhring C, Scheidegger D, Samaridis J, Cella M, Colonna M. A human killer inhibitory receptor specific for HLA-A3. J Immunol 1996 : 156 : 3098 3101. (Pubitemid 26123520)
45. Moretta A, Sivori S, Vitale M et al. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human Natural Killer cells. J Exp Med 1995 : 182 : 875 884.
46. Biassoni R, Cantoni C, Falco M et al. The HLA-C specific 'activatory' and 'inhibitory' Natural Killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J Exp Med 1996 : 183 : 645 650.
47. Bottino C, Sivori S, Vitale M et al. A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human Natural Killer cells and induces both triggering of cell functions and proliferation. Eur J Immunol 1996 : 26 : 1816 1824.
48. Stewart CA, Laugier-Anfossi F, Vély F et al. Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc Natl Acad Sci USA 2005 : 102 : 13224 13229.
49. Chewning JH, Gudme CN, Hsu KC, Selvakumar A, Dupont B. KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro. J Immunol 2007 : 179 : 854 868.
50. Mingari MC, Schiavetti F, Ponte M et al. Cytolytic T lymphocytes displaying natural killer (NK)-like activity. Expression of NK-related functional receptors for HLA-class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. Int Immunol 1995 : 7 : 697 703.
51. Mingari MC, Ponte M, Vitale C, Bellomo R, Moretta L. Expression of HLA-class I-specific inhibitory receptors in human cytolytic T lymphocytes: a regulated mechanism that controls T cell activation and function. Human Immunol 2000 : 61 : 44 50.
52. Moretta L, Romagnani C, Pietra G, Moretta A, Mingari MC. NK-CTL, a novel HLA-E-restricted T cell subset. Trends Immunol 2003 : 24 : 136 143.
53. Vivier E, Anfossi N. Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future. Nat Rev Immunol 2004 : 4 : 190 198.
54. Ruggeri L, Capanni M, Urbani E et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002 : 295 : 2097 2100.
55. Velardi A, Ruggeri L, Moretta A, Moretta L. NK cells: a lesson from mismatched hematopoietic transplantation. Trends Immunol 2002 : 23 : 438 444.
56. Sivori S, Cantoni C, Parolini S, Marcenaro E, Moretta L, Moretta A. IL21 induces both rapid maturation of human CD 34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors. Eur J Immunol 2003 : 33 : 3439 3447.
57. Shilling HG, Young N, Guethlein LA et al. Genetic control of human NK cell repertoire. J Immunol 2002 : 169 : 239 247.
58. Shilling HG, McQueen KL, Cheng NW, Shizuru JA, Negrin RS, Parham P. Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation. Blood 2003 : 101 : 3730 3740.
59. Ciccone E, Pende D, Viale O et al. Involvement of HLA class I alleles in NK cell specific function: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2). J Exp Med 1992 : 176 : 963 971.
60. Ciccone E, Pende D, Vitale M et al. Self Class I molecules protect normal cells from lysis mediated by autologous Natural Killer Cells. Eur J Immunol 1994 : 24 : 1003 1006.
61. Costello RJ, Sivori S, Marcenaro E et al. Defective expression and function of Natural Killer cell triggering receptors in patients with acute myeloid leukemia. Blood 2002 : 99 : 3661 3667.
62. Moretta L, Bottino C, Pende D, Castriconi R, Mingari MC, Moretta A. Surface NK receptors and their ligands on tumor cells. Semin Immunol 2006 : 18 : 151 158.
63. Bonnet D, Warren EH, Greenberg PD, Dick JE, Riddell SR. CD 8+ minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukaemia stem cells. Proc Natl Acad Sci USA 1999 : 96 : 8639 8644.
64. Molldrem JJ, Lee PP, Wang C et al. Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukaemia. Nat Med 2000 : 6 : 1018 1023.
65. Aversa F, Terenzi A, Tabilio A et al. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol 2005 : 23 : 3447 3454.
66. Pende D, Spaggiari GM, Marcenaro S et al. Analysis of the receptor-ligand interactions in the NK-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias. Evidence for the involvement of the poliovirus receptor (CD155) and Nectin-2 (CD112). Blood 2005 : 105 : 2066 2073.
67. Vitale M, Carlomagno S, Falco M et al. Isolation of a novel KIR2DL3-specific mAb: comparative analysis of the surface distribution and function of KIR2DL2, KIR2DL3 and KIR2DS2. Int Immunol 2004 : 16 : 1459 1466.
68. Trundley A, Frebel H, Jones D, Chang C, Trowsdale J. Allelic expression patterns of KIR3DS1 and 3DL1 using the Z27 and DX9 antibodies. Eur J Immunol 2007 : 37 : 780 787.
69. Pende D, Marcenaro S, Falco M et al. Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. Blood 2009 : 113 : 3119 3129.
70. Aversa F, Tabilio A, Terenzi A et al. Successful engraftment of T-depleted haploidentical 'three-loci' incompatibile transplants in leukaemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 1994 : 84 : 3948 3955.
71. Shlomchik WD, Couzens MS, Tang CB et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 1999 : 285 : 412 415.
72. Della Chiesa M, Vitale M, Carlomagno S, Ferlazzo G, Moretta L, Moretta A. The Natural Killer cell mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Eur J Immunol 2003 : 33 : 1657 1666.
73. Marcenaro E, Cantoni C, Pesce S et al. Uptake of CCR7 and acquisition of migratory properties by human KIR + NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction. Blood 2009 [Epub ahead of print].
74. Fernandez NC, Treiner E, Vance RE, Jamieson AM, Lemieux S, Raulet DH. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 2005 : 105 : 4416 4423.
75. Kim S, Poursine-Laurent J, Truscott SM et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 2005 : 436 : 709 713.
76. Anfossi N, André P, Guia S et al. Human NK cell education by inhibitory receptors for MHC class. Immunity 2006 : 25 : 331 342.
77. Asai O, Longo DL, Tian ZG et al. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. J Clin Invest 1998 : 101 : 1835 1842.